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Abstract
Crosslinked polystyrene codivinylbenzene adsorbent microspheres with median diameters 
between 40 and 300 micrometres, with an enhanced proportion of mesopores in the range 
4-10 nm, have  been synthesised using a membrane emulsification technique. The aim 
was to develop an adsorbent for the selective removal of middle molecular weight uraemic 
toxins (size range 0.5 – 20 kDa), e.g. 2-microglobulin (11.8 kDa), whilst size-excluding 
larger blood proteins e.g. serum albumin (MW 69 kDa). Using inverse size exclusion 
chromatography, the role of size exclusion has been demonstrated using hen egg 
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lysozyme (a surrogate for 2-microglobulin) and human serum albumin as model proteins 
for batch adsorption studies. The adsorbent sample possessing a nanoporous structure 
with pores predominantly smaller than 10 nm successfully size-excludes serum albumin 
whilst displaying significant adsorption capacity for the middle molecular weight lysozyme 
(14.3 kDa).
Keywords: Middle molecular weight toxins; haemoadsorption; inverse size exclusion 
chromatography; haemodialysis; microspheres; membrane emulsification
1. Introduction
Worldwide, around 1.8 million people are undergoing treatment for end-stage renal 
disease (ESRD) [1], of which around 1.4 million (~77%) are on dialysis treatment (89% of 
which are on haemodialysis and 11% on peritoneal dialysis) and the rest (23%) are living 
with a functioning renal transplant. Haemodialysis membranes are permeable to low 
molecular weight solutes, however, the removal of potent middle molecular weight uraemic 
toxins by this method is quite incomplete [2].  While the identity of many of these toxins 
remains unknown, elevated blood concentrations of certain middle molecular weight 
proteins (MMW ~ 10 kDa – 20 kDa) such as 2-microglobulin (2M, MW 11.8 kDa) have 
been associated with amyloid deposition [3] and inflammatory cytokines (e.g. IL-1, MW 
~18 kDa) have been associated with an elevated level of immune system activity [4].  
These are important target molecules for extracorporeal removal.  In established renal 
failure, many other molecules in the MMW range accumulate [5].
An alternative to haemodialysis is to bring the blood extracorporeally in contact with a 
biocompatible adsorbent.  There is increasing interest in the development of adsorption-
based systems for the non selective removal of toxins from blood for the treatment of 
uraemia [6], sepsis [7] and drug overdose [8].  A commercially available polymeric 
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adsorbent (Lixelle, Kaneka, Japan) designed for the removal of 2M is being used in Japan 
for the purification of haemodialysis patients’ blood. The adsorbent beads are porous 
cellulose, modified with hexadecyl groups that adsorb 2M by nonspecific hydrophobic 
interactions.  Patients treated with the Lixelle column have been shown to have 
significantly lower levels of 2M (60–70% reduction compared with initial levels after a 4–5 
h treatment session) and concomitantly improved symptoms, including a better ability to 
undertake daily activities, reduced joint stiffness and pain, as well as a reduction of the 
appearance of bone cysts [9]. The Lixelle adsorbent capacity is reported to be around 1 
mg 2M per cm3 of adsorbent [10]. During a 4–5 h haemoperfusion treatment session, a 
350 cm3 column removed 210 mg of 2M [10] (the typical serum concentration of 2M in 
renal patients is around 35 mg l-1).  The Lixelle column has also been shown to 
nonspecifically remove middle molecular weight plasma cytokines (IL-1, IL-6, IL-8 and 
TNF-) in humans with sepsis [11].  At the present time, this treatment is only undertaken 
in Japan and its (high) cost may exceed the value of the clinical benefits.  Other 
researchers have investigated the use of immobilized antibody-functionalized adsorbents 
for the selective removal of 2-M [12]. Reported adsorption capacity (0.4 mg 2M cm-3
adsorbent) was comparable with the Lixelle adsorption data, but this approach is even 
more expensive.
There is therefore a strong motivation to develop new, less costly polymeric adsorbents 
possessing suitable physicochemical attributes that may prove clinically beneficial.  We 
wondered whether such attributes might be achieved relatively simply by tailoring the 
mesoporous structure (4–10 nm range) using conventional suspension polymerization 
synthesis techniques.  Ideally the external bead surface should have low affinity for all 
proteins;for example, by employing an ultrahydrophilic external surface coating for the 
adsorbent bead (see Figure 1); and may require surface modification to reduce adverse 
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interactions with blood that may lead to platelet activation, etc., -- proteins adsorbing on 
hydrophobic surfaces are likely to be permanently denatured [13] and recognised as 
foreign by the immune system.  The walls of the internal pores should have high affinity for 
all proteins (e.g., but could through nonspecific hydrophobic interactions). Suitable 
polymeric adsorbents must furthermore fulfil a number of clinical requirements: inter alia, 
during haemodialysis, the amount of heparinized blood in the extracorporeal circuit (whose 
volume is typically 250–300 cm3) and the time a portion of blood spends in the 
extracorporeal circuit is necessarily limited (typical blood flow rate during haemodialysis is 
250–400 cm3 min-1) to prevent blood coagulation and minimize platelet activation. In terms 
of an efficient blood purification column, these requirements translate into the following 
design criteria: (i) small column size, implying a high adsorption capacity per unit volume; 
(ii) fast adsorption kinetics, (implying a small bead size with a short diffusion path length); 
(iii) low pressure drop across the column, (implying a short bed length) and preferably 
monosized beads to avoid low bed porosity.
Physiologically essential blood proteins such as serum albumin (HSA, MW 69 kDa) are 
present at a very high concentration (HSA 40 g l-1 compared with 2M ~ 35 mg l-1), and 
ideally they should not be removed during haemoperfusion.  Moreover, if adsorption  were 
nonspecific, the high concentration (3 orders of magnitude higher than 2M!) of HSA would 
flood the adsorbent surface with HSA and lead to very inefficient removal of the uraemic 
toxins (14).  Bearing in mind that ideally the adsorbent should remove a range of middle 
molecular weight molecules (i.e., smaller than albumin and other abundant blood proteins 
such as immunoglobulin and fibronectin), selectivity for the toxins in the presence of 
competing solutes may conveniently be achieved by size exclusion (Figure 1); the 
hydrodynamic diameter of HSA is ~7 nm and of MMW toxins such as 2M ~4 nm. Note 
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that size exclusion is routinely employed for the analytical determination of polymer 
molecular weights (size exclusion chromatography, SEC).
Control of pore structure in crosslinked polymeric resins has been investigated widely in 
the literature [15-30], with the conclusion that controlling the maximum pore size in an 
adsorbent bead requires judicious selection of the diluents used as porogens; and the 
crosslinking degree and to a lesser extent polymerization temperature and initiator (type 
and concentration) influence the pore structure within the polymer adsorbent bead.
Since the adsorption process requires the toxin to diffuse within the adsorbent bead 
(where most of the surface for adsorption is present), the kinetics of the process will be 
limited by intrabead mass transfer and hence depend on the size of the adsorbent beads. 
There are two conflicting factors at play here, (i) whilst a small bead size will result in faster 
toxin removal kinetics (desirable), the price to be paid will be (ii) a high external surface 
area per unit volume of packed-bed, which may result in adverse blood-surface 
interactions and certainly a higher pressure drop across the adsorbent packed-bed.  This 
is undesirable since shear damage to blood (leading to haemolysis) is clinically dangerous.
The aim of the work presented here was to develop an adsorbent material that would 
successfully size-exclude serum albumin while allowing middle molecular weight proteins 
access to the internal surface of the adsorbent. We have focused on copolymers of 
styrene divinylbenzene, PSDVB, because they are known to be good hydrophobic 
adsorbents.
2. Experimental Materials and Methods
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2.1. Adsorbent Preparation
During the suspension polymerization process, a mixture of styrene and divinylbenzene 
(oil phase) was dispersed in an aqueous solution (the continuous phase) using a novel 
membrane emulsification process (described below). The reaction was initiated using 
benzoyl peroxide as the initiator (1% of the monomer concentration by weight). Porogens 
studied included toluene and mixtures of toluene with precipitating media such as 
undecane and naphthalene.  The exact compositions of the monomer phase can be seen 
in Table 1.  The monomer to porogen ratio was kept at 1:1 by weight.  The nomenclature 
used to label the adsorbents is explained by the following example: PSDVB3:5TolNap5:2 
(from Table 1) was prepared by mixing equal amounts (w/w) of a mixture containing 
styrene and DVB (ratio 3:5) with a porogen mixture of toluene and naphthalene (ratio 5:2).
The emulsion droplets were stirred throughout the reaction period and stabilized using 
poly(vinyl alcohol) (PVA) to keep the droplets from coalescing during the “sticky” phase. 
Once the polymerization reaction was complete, the polymer beads were separated from 
the continuous phase by filtration.
2.2. Membrane emulsification
A conventional stirred tank system for generating an O/W (oil in water) emulsion results in 
a heterogeneous population of droplet sizes due to the nonuniformity of the shear field.  
Hence a membrane emulsification process was investigated (Figure 2).  By using a 
controlled pore size membrane (supplied by Micropore Technologies (UK) Ltd) a much 
narrower size distribution than via the conventional method can be produced.  For the 
production of beads with a mean size of 40 µm, a circular 10 µm pore membrane was 
used. The monomer mixture was injected through the membrane into the aqueous solution 
using a syringe pump at an injection rate of 0.4 cm3 min-1. The droplets were sheared off 
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the membrane surface using a paddle stirrer.  The continuous phase used to stabilize the 
oil droplets was a solution of 3% w/w PVA (Mowiol™ 40-88) and 3.3% w/w NaCl. The 
droplet size was controlled by shear at the membrane surface (influenced by the viscosity 
of the continuous phase and by the stirrer speed) and membrane pore size.
The droplets formed in the dispersion cell were then transferred to a reaction vessel 
containing an aqueous solution of 4.5% PVA and 3.3% NaCl. The polymerization reaction 
was carried out at 80 °C for 24 h. Adsorbent beads were subsequently separated using a 
Buchner funnel and Whatman GF/B glass fibre filters, washed with hot distilled water to 
remove the PVA and NaCl and rinsed with acetone to remove any residual water, and 
soxhlet extracted for 8 h with toluene to remove any unreacted monomers. Finally, the 
adsorbent beads were dried under vacuum at ambient temperature overnight. Bead sizes 
were evaluated using a Coulter LS130 instrument. The amount of material produced per 
batch was typically ~50 cm3 of beads compared with ~100 cm3 from a conventional stirred 
tank system.
2.3. Inverse Size Exclusion Chromatography
Size exclusion chromatography [31-33] is conventionally used to size-separate solutes, e.g. 
proteins [34, 35] that . It is routinely used for the determination of the molecular weight 
distribution of polymer samples [36]. Inverse size exclusion chromatography (ISEC) may 
be used to investigate the pore structure of a swollen polymer adsorbent [37-41]. The 
technique employs a number of probe molecules (normally polymers of narrow molecular 
weight distribution) that do not interact with the surface of the adsorbent material. The 
retention time of each probe within a packed column of the adsorbent material reflects the 
degree to which the probe is prevented from accessing the pore volume of the adsorbent 
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beads (and consequently the adsorbent bed). This can be expressed as the exclusion 
coefficient, Kd, which is defined as:
Kd = 
VR - V0
VT - V0
(1)
where VR is the solute elution volume, V0 is the interparticle void volume and VT is the total 
mobile phase volume. A probe molecule too large to enter the adsorbent beads allows the 
characterization of the interparticle void volume (V0), and by using a molecule small 
enough to enter all the pores, total accessible mobile phase volume (VT) is quantified. 
Thus for each calibration probe of intermediate size, the corresponding Kd may be 
determined. The retention volumes and retention times are related by the flow rate of the 
mobile phase, i.e.
Kd = 
tR - t0
tT - t0
(2)
where tR is the solute retention time, t0 is the retention time of the excluded probe and tT is 
the retention time of the probe that can access the whole pore volume. Thus, values for Kd
range from 0 (completely excluded probe) to 1 (probe that can access the whole pore 
structure), and 1 – Kd  gives the fraction of the pore volume inaccessible to a particular 
probe molecule.
For analysis of the PSDVB the mobile phase was tetrahydrofuran (THF), and the probe 
molecules were various low polydispersity calibration polystyrenes and toluene (the 
smallest). Table 2 shows the relationship between polymer probe molecular weight and 
the solute viscosity radius Rη (in cm) is given by the relation:
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  3
1
A
η N10
Mη3
R 


  (3)
where NA is Avogadro’s number, M is the solute molecular weight and [] is the intrinsic 
viscosity (cm3 g-1) [37]. Rη accounts for both the solute mass and shape (which are also 
reflected in the intrinsic viscosity) and thus is used as a universal calibration parameter for 
SEC.
Adsorbents with modal bead sizes of 30–40 µm were swollen in THF for 24 h before being 
slurry-packed under pressure (250 bar) into stainless steel columns 4.6 mm in diameter 
and 25 cm long. After packing, THF was passed through the columns overnight at a flow 
rate of 0.1 cm3 min-1 to ensure the bed was settled and any impurities removed. The 
conditions for the analysis were: column temperature 35 C, THF flow rate 0.5 cm3 min-1
(Kontron Instruments HPLC pump 420), and 100 µl of 1.5 g l-1 polystyrene standard 
solution were injected.  Detection of the standards was with a Perkin Elmer u.v./vis. 
Lambda 2 spectrometer fitted with a flow cell operating at a wavelength of 254 nm.  
Retention times for each standard were compiled and values for Kd calculated according to 
eqn (2).
2.4. Porosity/Pore Size Distributions
The pore size distributions of the various adsorbents produced were analysed in the dry 
state using nitrogen adsorption (77 K) on a Micromeritics ASAP 2000 instrument. 
Additionally, data for Amberlite XAD4 (Rohm & Haas), a commercially available and widely 
studied styrene co-divinylbenzene mesoporous adsorbent, is also reported as an example 
of a widely used adsorbent. All of the adsorbents were dried overnight from toluene under 
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vacuum at ambient temperature. The nitrogen isotherm was fitted with the BET model to 
evaluate the surface area, and total pore volume was also recorded.  Incremental and 
cumulative pore size distributions were evaluated from the nitrogen adsorption isotherm 
data using mean-field density functional theory (DFT) [42].
2.5. Albumin and lysozyme uptake
The prohibitively high cost of 2-M for the physicochemical characterization experiments 
led us to seek a low-cost protein of similar size to 2-M, and readily available in a pure 
state. Lysozyme (hen egg white, MW 14.4 kDa, size ~ 4 nm) was used as a surrogate for 
2-M (MW 11.8 kDa, size ~ 4 nm). The purpose of the single solute in vitro adsorption 
studies was to demonstrate the accessibility of the adsorbent internal surface to solutes of 
size ~ 4 nm and concomitant rejection of the significantly larger HSA (and a fortiori the 
even larger immunoglobulins).
Characterising adsorbents in terms of adsorption capacity and adsorption kinetics is 
possible experimentally using a batch stirred tank reactor.  The time to equilibrate/saturate 
the adsorbent with protein diffusing from the bulk solution to the interior of the adsorbent 
particle depends on the particle size of the adsorbent beads and the effective diffusivity of 
the protein in the interior of the adsorbent.  A small number of experiments under carefully 
controlled conditions was undertaken.
The dynamic batch adsorption experiments were conducted in a thermostated (37 C) 0.5 l 
stirred tank reactor fitted with an overhead agitator and baffles. Influence of stirrer agitation 
rate on the kinetics of the adsorption process was investigated and the stirrer agitation 
speed was selected such that external mixing effects no longer influenced the kinetics of 
the adsorption process (Biot number Bi  = kfRp/De > 100, where kf is the external film mass 
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transfer coefficient, Rp the bead radius and De the solute effective diffusivity in the 
adsorbent pores). 0.5 l of pH-buffered (containing HEPES at a concentration of 10 mM, 
NaCl 100 mM, pH 7.2) protein solution (containing either lysozyme at an initial 
concentration of 100 mg l-1 or human serum albumin at an initial concentration of 200 mg l-
1) was brought into contact with a known amount of preswollen adsorbent, XAD4 or 
PSDVB3:5TolNap5:2. Solution samples were taken at regular intervals until no change in 
solution protein concentration was recorded. The solution protein concentration was
measured using reverse phase HPLC (Agilent 1100 series) equipped with a diode array 
detector (detection wavelength  = 230 and 290 nm for albumin and lysozyme, 
respectively) and a C18 analytical column (Supelco, UK). The mobile phases were A: 
ultrapure water with 0.5% trifluoroacetic acid (TFA) and B: acetonitrile with 0.1% TFA.  A 
linear gradient was used starting at (98% A : 2% B) and ending at (20% A: 80% B) over 60 
minutes followed by a step change back to (98% A : 2% B) for 10 minutes to equilibrate 
the column for the next sample. The combined mobile phase flow rate was set at 1 cm3
min-1, the column temperature was set at 40 C and the sample injection volume used was 
100 l. The reported adsorption capacity values (q*, mg g-1) correspond to saturation 
protein uptake values whereas the fractional uptake F(t) = q(t)/q* represents the 
normalised uptake at a given time point (t).
3. Results and Discussion
3.1. Bead Size Control
Figure 3 shows representative bead size distributions for two of the materials generated 
using the membrane emulsification technique.  The data illustrate the effect of shear at the 
membrane surface on the droplet size distribution. Median diameters within the range of 
30 to 300 m could be controllably produced. Table 3 summarizes the bead size 
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information for the three adsorbents studied using the inverse size exclusion 
chromatography (ISEC) technique.
Adsorbents used in fixed-bed haemoperfusion systems tend to have bead sizes larger 
than 300 m. The ISEC work required the bead size to be an order of magnitude smaller 
(to aid resolution of the different probe retention peaks). Thus, the effect of the smaller 
bead size on the resulting pore size distribution was evaluated. Nitrogen 
adsorption/desorption data was obtained for two PSDVB3:5TolUn1:0 samples with median 
bead sizes of 37 and 120 µm respectively. It is evident from Figure 4 that the pore 
structure is essentially invariant for polymerization within oil droplets of different sizes over 
this range. Thus, we can infer that ISEC measurements on material of smaller average 
size may be used to provide insight into the pore structure of larger beads prepared under 
similar suspension polymerization conditions.
3.2. Control of pore structure
The three monomer and porogen combinations investigated in the present study focus on 
the use of toluene, a good solvent for polystyrene, to generate small pores, thereby 
reducing the maximum pore size. Figure 5 shows the normalized incremental pore volume 
distributions for the materials studied. Table 4 provides a summary of the BET surface 
area, total pore volume and discretized surface area and pore volumes for pores in the 
ranges 2–10 nm and 10–50 nm.
Comparing the pore structure of the adsorbent sample prepared using undecane 
(PSDVB1:1TolUn9:1) with XAD4 shows that while having different overall surface areas 
and pore volumes (Table 4), the two samples have similar pore size distributions (Figure 
5), especially in the region above 10 nm.  PSDVB3:5TolUn1:0 and PSDVB3:5TolNap5:2 
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both have similar cut-offs at ~20 nm; however, PSDVB3:5TolNap5:2 has a smaller fraction 
of its pores in the region above 10 nm, which was the desired synthesis objective for 
promoting serum albumin exclusion.
Analysis of the adsorbent materials in the swollen state was done using ISEC themain 
drawback of which is the requirement that the mobile phase be THF (to minimize 
nonspecific interactions between polystyrene probes and the adsorbent), a good solvent 
for polystyrene. This may result in polymer segment swelling with the undesirable effect of 
changing the internal pore structure compared with that of the polymer when suspended in 
water or in contact with blood. There is however evidence that low-temperature vacuum 
drying of a crosslinked polymeric adsorbent (medium to high crosslinking density) from a 
solvent (either a poor or a good one) followed by nitrogen porosimetry may allow the 
porous structure in that solvent to be retained and hence recorded [21]. Thus, if the 
maximum pore size (pore cut-off) of the methanol-dried adsorbent (methanol is a poor 
solvent for polystyrene) is the same as that for a toluene-dried sample, then it is 
reasonable to assume that the results from the ISEC technique may be used to predict the 
molecular weight cut-off for the adsorbent samples in THF. The adsorbents prepared in 
this study have a high crosslinking degree and would be expected to have a stable pore 
structure in any case. Figure 6 shows the cumulative pore volume distributions of 
PSDVB3:5TolNap5:2 when dried from toluene, acetone and methanol respectively. Figure 
6 clearly shows that there are differences in the pore volumes for this material when 
swollen in different solvents.  The normalized data would highlight any differences in the 
distribution of pores due to swelling in different solvents.  As the normalized distributions 
overlay on one another, this suggests that while the total pore volume changes, the 
distribution of the pores (greater than ~1 nm) and the pore cut-off remains unchanged. 
Hence we may use ISEC with confidence.
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3.3. ISEC
Eight polystyrene standards in THF were used to probe the three adsorbents under 
investigation. XAD4 was not evaluated using ISEC as commercial material is not available 
in the appropriate bead size range (less than 50m); PSDVB1:1TolUn9:1 with its 
comparative pore structure was used as a surrogate for XAD4. 8 probe standards and 
toluene (see Table 2) were individually injected into the column packed with the adsorbent 
material and a composite chromatogram overlaying all the peaks for each sample was 
generated (see Figure 7). From these chromatograms, the exclusion coefficients Kd were 
calculated (eqns (1) and (2)). Kd represents the fraction of the pore volume which the 
probe is able to access and this has been plotted in Figure 8 for the PSDVB1:1TolUn9:1 
and PSDVB3:5TolNap5:2 polymer samples.
Serum albumin has a nominal size of ~7 nm (hydrodynamic radius ~ 3.5 nm). Reference to 
data in Table 2 shows that this falls between polystyrene probe standards PS 10 kDa, Rη
2.8 nm and PS 20 kDa, Rη 4.7 nm. The chromatogram for PSDVB1:1TolUn9:1 (Figure 7A) 
clearly shows that the 20 kDa polystyrene probe (peak 7) is able to enter some part of the 
adsorbent pore structure. The chromatogram for PSDVB3:5TolNap5:2 shows the peak for 
the 20 kDa polystyrene standard bunched up with the peak for the 1 MDa polystyrene 
standard, implying rejection of the probe from the adsorbent. Resolution of probes below 
10 kDa is possible with the adsorbent material packed in this column. Figure 8 shows the 
fraction of the pore volume accessible to albumin-sized probes. Thus, on the basis of the 
ISEC data, the adsorbent material PSDVB3:5TolNap5:2 possesses a well defined 
mesopore structure (< 10 nm) capable of size-excluding serum albumin whilst allowing 
middle molecular weight solutes access to the internal surface of the adsorbent.
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3.4. Albumin and lysozyme uptake
Analysis of protein equilibrium uptake data
The protein adsorption data obtained for XAD4 and PSDVB3:5TolNap5:2 are presented in 
Table 5. The saturation capacity values (q*) for lysozyme (LYZ) were 59 mg g-1 for 
PSDVB3:5TolNap5:2 and 330 mg g-1 for XAD4. The saturation capacity values (q*) for 
human serum albumin (HSA) were 2.2 mg g-1 for PSDVB3:5TolNap5:2 and 95 mg g-1 for 
XAD4. The adsorption capacity values were found to be concentration-independent 
(irreversible adsorption). This is fairly common for single protein adsorption studies, where 
surface coverage has been found in many cases to equate to quasi-monolayer adsorption 
[43, 44]. The protein saturation capacity values were found to correlate with the surface 
area accessible to lysozyme (22 m2 g-1) and albumin (0.9 m2 g-1) for PSDVB3:5TolNap5:2 
(nitrogen porosimetry data) determined on the basis of size exclusion from pores smaller 
than 6 nm for lysozyme and 14 nm from albumin. This corresponds to surface coverage 
of 2.7 mg m-2 for lysozyme and 2.4 mg m-2 for albumin. Analysis of protein saturation data 
for XAD4 using a similar basis as for PSDVB3:5TolNap5:2 yields the surface areas 
accessible to lysozyme (120 m2 g-1) and albumin (40 m2 g-1). This corresponds to  = 2.8 
mg m-2 for lysozyme and 2.4 mg m-2 for albumin. These values are comparable to jammed, 
randomly adsorbed monolayer coverages reported previously [45, 46].
Batch adsorption dynamics
In addition to evaluation of the protein saturation uptake, time series data were modelled 
using the irreversible adsorption model proposed by Suzuki and Kawazoe [47] to extract 
solute intraparticle diffusivities (De). The adsorbent samples used were sieved to obtain
tight particle size fractions. Experiments were performed using a single dissolved protein in 
0.1M Hepes buffer solution.  A summary of the values of the experimental variables used 
for the batch adsorption experiments are provided in Table 6.  The stirrer speed was set to 
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726 rpm as this was found to minimise external film mass transfer resistance to solute 
diffusion permitting evaluation of the intraparticle diffusional resistance to mass transfer.
The 1st order differential equation derived by Suzuki et. al. [47] relating the change in 
solute concentration in the tank to uptake by the adsorbent was solved using Matlab 
software (version 7). The best fit value of the effective solute diffusivity De was found by 
minimising the sum of the squares of the errors (difference between the model prediction 
and the experimental data). The best fit intraparticle diffusivity values De evaluated for LYZ 
and HSA adsorption by PSDVB3:5TolNap5:2 and XAD 4 are presented in Table 6. 
Experimental kinetic data plotted as fractional uptake F(t) curves are presented in Figure 9; 
the model predictions are shown as solid curves.
The fitted intraparticle diffusivity values De obtained for the lysozyme adsorption data 
suggested that the uptake kinetics for PSDVB3:5TolNap5:2 (De = 4 x 10
-13 m2 s-1) are in 
order of magnitude slower in comparison with XAD4 (De = 4 x 10
-12 m2 s-1). The data in 
Figure 9 shows slower lysozyme uptak  by XAD4 due to the larger particles size for XAD4 
(dp = 576 m) compared with PSDVB3:5TolNap5:2 (dp = 28 m).  The slower adsorption 
kinetics may be attributed to the tighter mesopore structure within PSDVB3:5TolNap5:2, 
manifested in a reduction in the magnitude of the effective diffusivity of the solute within 
the adsorbent particle.
HSA (De = 5 x 10
-11 m2 s-1) adsorption kinetics for XAD4 was found to be faster in 
comparison with lysozyme (De = 4 x 10
-12 m2 s-1) removal. HSA is able to access only a 
fraction of the adsorbent pore structure, which appears to provide little hindrance to the 
diffusion of the solute.  The effective diffusivity is similar in magnitude to the free solution 
diffusivity for HSA (6.1 x 10-11 m2 s-1). PSDVB3:5TolNap5:2 adsorption capacity for HSA 
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was small suggesting predominantly adsorption on the external bead surface. The fitted 
intraparticle diffusivity was similar in magnitude to the free solution diffusivity for HSA (6.1 
x 10-11 m2 s-1).
4. Conclusions
Controlling the internal pore structure of poly(styrene-divinylbenzene) adsorbents (pore 
size less than 10 nm) is a route to enabling the removal of middle molecular weight 
proteins whilst excluding larger molecules like serum albumin. A styrene-containing 
adsorbent (PSDVB3:5TolNap5:2) has been engineered using a membrane emulsification 
technique and it has been demonstrated that microspheres with median bead diameters in 
the range of 30 to 300 m can be prepared by the process. The microspheres have been 
shown to size-exclude serum albumin whilst allowing removal of smaller proteins 
(lysozyme, a surrogate for middle molecular weight uraemic toxins). The use of ISEC to 
probe the pore structure of synthesized adsorbents has proved useful in demonstrating the 
influence of pore structure control on the size rejection behaviour. The adsorption data 
provides evidence of the albumin size exclusion phenomena and is currently being 
investigated in more detail. Preliminary dynamic adsorption studies suggest hindered 
transport of middle molecules due to the narrow pore size distribution needed to size-
exclude human serum albumin.
The kidney is of course an amazingly complex organ [48], and a size-selective adsorbent 
can of course only provide a very partial replacement of its function, but in the case of 
renal failure the clinical options are limited, and an improvement in the current poor 
removal of uraemic toxins by haemodialysis would be of great value for public health.  The 
work reported here is a step in this direction.
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Figure 1. Schematic diagram of a size selective adsorbent bead, with a nanoporous structure suitable for 
size exclusion of HSA whilst permitting smaller proteins e.g. lysozyme, to diffuse within.
Figure (1)
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Figure 2. Schematic diagram of emulsion generation in a dispersion cell (left) and micrographs of a circular pore 
membrane (lower right, courtesy of Micropore Technologies) and a polymer droplet emulsion (size range 130–170 m)
generated using the dispersion cell (upper right).
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Figure (2)
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Figure 3. Particle size distributions for polystyrene co-divinylbenzene resins prepared using a 10m circular pore 
membrane (Micropore Technologies) but with different PVA concentrations and shear rates.  Coefficients of variation 
(CV) were typically around  20%, compared with 40% for materials prepared using a conventional stirred tank system.
Figure (3)
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Figure 4. Incremental pore volume distribution for PSDVB3:5TolUn1:0 (prepared as beads of median diameters of 37 
and 120 m).
Figure (4)
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Figure 5. Normalised incremental pore volume distributions resulting from the use of different porogens.
Figure (5)
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Figure 6. Cumulative and normalized (to the total cumulative volume) cumulative pore volume distributions for 
PSDVB3:5TolNap5:2 dried from different solvents.
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Figure (6)
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Figure 7. ISEC chromatograms for (A) PSDVB1:1TolUn9:1 and (B) PSDVB3:5TolNap5:2 polymer samples.
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Figure (7)
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Figure 8. Percentage of pore volume accessible to probes determined from ISEC, comparison of PSDVB1:1TolUn9:1 
and PSDVB3:5TolNap5:2 polymer samples (lines connecting the points are merely to guide the eye).
Figure (8)
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Figure 9. Fractional uptake (q(t)/q*) versus adsorption time, comparison of PSDVB3:5TolNap5:2 polymer sample (open 
triangles – LYZ data; solid triangles – HSA data) and XAD4 polymer sample (open diamonds – LYZ data; solid diamonds
– HSA data). Solid lines are the irreversible isotherm model predictions for the data.
Figure(9)
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Table 1. Monomer phase compositions for polymer samples, all ratios w/w.
Porogens
Sample i.d.
Ratio of 
Styrene 
to DVB
Nominal 
Crosslinking 
%
1 2
Ratio of 
Porogens 
(1:2)
PSDVB3:5TolNap5:2 3:5 50 Toluene Naphthalene 5:2
PSDVB3:5TolUn1:0 3:5 50 Toluene - 1:0
PSDVB1:1TolUn9:1 1:1 40 Toluene Undecane 9:1
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Table 2. Polystyrene probe weight average molecular weight (MP), polydispersity index 
(PDI) and viscosity radius (Rη).
Probe MP / kDa PDI Rη / nm
a
Toluene 0.092 1 -
PS 0.5 kDa 0.374 1.22 0.4
PS 1 kDa 0.89 1.12 0.7
PS 2 kDa 1.92 1.06 1.1
PS 5 kDa 4.87 1.05 1.8
PS 10 kDa 9.95 1.03 2.8
PS 20 kDa 24.3 1.02 4.7
PS 70 kDa 76 1.03 9.1
PS 1000 kDa 1044 1.14 42.6
a - Calculated values [41].
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Table 3. Average bead sizes of the adsorbents used in ISEC.
Particle Diameter / mSample i.d.
Mean Median Mode
PSDVB3:5TolNap5:2 29 28 30
PSDVB1:1TolUn9:1 29 30 36
PSDVB1:1TolUn1:0 34 37 39
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Table 4. Surface area and pore volume measurements for polymer adsorbents.
BET DFT
Surface Area / 
m2 g-1
Pore Volume / 
cm3 g-1Sample i.d. Surface 
Area / 
m2 g-1
Pore 
Volume / 
cm3 g-1 2 - 10 
nm
10 - 50 
nm
2 - 10 
nm
10 - 50 
nm
PSDVB3:5TolNap5:2 412 0.34 88 4 0.18 0.03
PSDVB3:5TolUn1:0 478 0.41 101 9 0.21 0.05
PSDVB1:1TolUn9:1 356 0.47 76 26 0.18 0.19
Amberlite XAD4 830 1.1 222 51 0.5 0.36
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Table 5. Lysozyme (LYZ) and Albumin (HSA) total adsorption capacity q* and  values for 
adsorbent materials.
Sample i.d. LYZ HSA
q* / 
mg g-1
a / 
mg m-2
Area 
accessible / 
m2 g-1
q* / 
mg g-1
b / 
mg m-2
Area 
accessible 
/ m2 g-1
PSDVB3:5TolNap5:2 59  7 2.7 22 2.2  1 2.4 0.9
XAD4 330  60 2.8 120 95  5 2.4 40
a approximate footprint of lysozyme, 9 nm2; b approximate footprint of albumin, 49 nm2
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Table 6. Summary of experimental variables used for measuring LYZ and HSA batch 
adsorption dynamics
TN_5:2 TN_5:2 XAD4 XAD4
Solute LYZ HSA LYZ HSA
Particle size, d3,2 x 10
6 (m) 28 197 576 163
Mass of sorbent, (g) 2.5 22 5 0.5
Co, (mg/l) 402 204 5361 200
Cf, (mg/l) 107 106 2058 105
Saturation uptake, q* (g/g) 0.059 0.0022 0.330 0.095
Stirrer speed, rpm (min-1) 726 726 726 726
Porosity,  (-) 0.29 0.29 0.55 0.55
Solid density,  (kg/m3) 1040 1040 1120 1120
Intraparticle Diffusivity, De x 10
12
(m2/s)
0.4 40 4 50
 Diffusivity in solution (1x10-10, m2/s);  Diffusivity in solution (6.1x10-11, m2/s)
